TB: Clinical Trials

5 trials for TB, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Completed 4, Recruiting 1

Follow TB: new trials by email Literature Review of TB trials Research Report on TB

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetic Study of Sudapyridine(WX-081)in Healthy Chinese Subjects
[U-14C] WX-081 - TB
Phase 1RecruitingShanghai Jiatan Pharmatech Co., Ltd102024-09-042024-11-22
A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
MVA 85A - HIV Infections, TB
Phase 1CompletedUniversity of Oxford482007-07-012011-03-28
Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines
MVA 85A - TB
Phase 1CompletedUniversity of Oxford2142006-10-012010-02-09
Study of the Safety and Immunogenicity of Bacille Calmette Guerin (BCG) Vaccine
BCG - TB
Phase 1CompletedUniversity of Oxford112004-02-012008-04-07
A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers
BCG - TB
Phase 1CompletedUniversity of Oxford112001-11-012007-05-31

Narrower conditions

Tuberculosis (3)  ·  Acquired Immunodeficiency Syndrome (1)  ·  HIV Infections (1)

Broader conditions

Actinomycetales Infections (3)  ·  Bacterial Infections (3)  ·  Bacterial Infections and Mycoses (3)  ·  Gram-Positive Bacterial Infections (3)  ·  Infections (3)  ·  Mycobacterium Infections (3)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Lentivirus Infections (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)  ·  Sexually Transmitted Diseases (1)

Interventions

MVA 85A (2)  ·  MVA Pfs25-IMX313 malaria vaccine (2)  ·  sudapyridine (1)

Sponsors

University of Oxford (4)  ·  Shanghai Jiatan Pharmatech Co., Ltd (1)

Countries

United Kingdom (2)  ·  China (1)  ·  South Africa (1)  ·  The Gambia (1)

Top investigators

Helen McShane (3)  ·  Helen I McShane (1)

Results publications

PMID 15502839, PMID 19529780, PMID 22281831, PMID 25466778